Online citations, reference lists, and bibliographies.
← Back to Search

Nivolumab Or Nivolumab Plus Ipilimumab In Patients With Relapsed Malignant Pleural Mesothelioma (IFCT-1501 MAPS2): A Multicentre, Open-label, Randomised, Non-comparative, Phase 2 Trial

Arnaud Scherpereel, Julien Mazieres, Laurent Greillier, Sylvie Lantuejoul, Pascal Dô, Olivier Bylicki, Isabelle Monnet, Romain Corre, Clarisse Audigier-Valette, Myriam Locatelli-Sanchez, Olivier Molinier, Florian Guisier, Thierry Urban, Catherine Ligeza-Poisson, David Planchard, Elodie Amour, Franck Morin, Denis Moro-Sibilot, Gérard Zalcman, Didier DEBIEUVRE, Sandrine HIRET, Jacques CADRANEL, Séverine FRABOULET-MOREAU, Delphine CARMIER

Cite This
Download PDF
Analyze on Scholarcy
Share